NRAS mutant melanoma: Targeted therapy, are we there yet?
22 Nov 2018
NRAS mutant melanoma: Targeted therapy, are we there yet?
Managing uncertainty in Spitz Nevi melanoma
Shall all Spitz-like tumours be excised?
Frailty of elderly patients after surgery
Making care packages for elderly cancer patients
The emerging era of no-completion lymph node dissection
Do we still need surgery in advanced melanoma?
Virtual reality for surgical training in low and middle income countries
Editor’s Choice for October 2018
Modern melanoma treatment in the UK
Combination strategies of immunotherapy in breast cancer
Latest concepts in the diagnosis of genetic ALL subtypes